文献速递肿瘤 PET/CT

用于黑色素瘤SPECT显像的99mTc标记黑色素靶向探针的研制

Development of 99mTc-labeled melanin-targeted probes for SPECT imaging of melanoma.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-04-21

本研究合成了六种99mTc标记的黑色素靶向探针,并在体外和小鼠模型中评估其理化性质、细胞摄取、生物分布及SPECT/CT显像。其中99mTc-SMIC-4006在B16F10黑色素瘤异种移植瘤中摄取最高(1小时为5.18±1.55%ID/g),显著高于非黑色素性A375异种移植瘤(p<0.01),SPECT/CT可清晰勾画B16F10肿瘤区域。作者认为99mTc-SMIC-4006是有前景的黑色素瘤SPECT探针。

要点

  • 六种99mTc标记探针的放射标记产率>95%,放射化学纯度>95%。
  • 99mTc-SMIC-4006在B16F10异种移植瘤1小时摄取为5.18±1.55%ID/g,显著高于A375(p<0.01)。
  • 99mTc-SMIC-4006的肿瘤/血比值1小时为4.30±0.63,6小时升至10.27±5.13。

核心结论

  • 99mTc-SMIC-4006是一种有前景的黑色素瘤SPECT探针,具有高肿瘤特异性、优异摄取和理想肿瘤/本底对比度,并具有较强临床应用潜力。

研究设计与样本

  • 本研究合成六种99mTc标记的黑色素靶向探针,在体外评估脂水分配系数、放射化学稳定性和细胞摄取,并在多种小鼠模型中进行体内生物分布、SPECT/CT显像、药代动力学、稳定性和生物相容性研究。

主要发现

  • 六种探针的放射标记产率>95%,放射化学纯度>95%。
  • 体外细胞摄取和阻断实验显示探针与黑色素结合的能力和特异性。
  • 99mTc-SMIC-4006在B16F10异种移植瘤1小时摄取最高,为5.18±1.55%ID/g,显著高于非黑色素性A375异种移植瘤(p<0.01)。
  • 99mTc-SMIC-4006的初始肿瘤/血比值1小时为4.30±0.63,6小时增至10.27±5.13。
  • 99mTc-SMIC-4006的SPECT/CT显像清晰勾画B16F10肿瘤区域、对比度高,而A375异种移植瘤摄取极少。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Melanoma is a highly aggressive skin cancer with poor prognosis, highlighting the need for early detection. This study aims to develop a 99mTc-labeled single photon emission computed tomography (SPECT) probe targeting melanin to improve melanoma detection with enhanced specificity and cost-effectiveness. METHODS: Six potential 99mTc-labeled probes were synthesized by conjugating small molecules with nitrogen-rich fatty chains or cyclic structures to 99mTc. These 99mTc-complexes were then assessed in vitro for their lipid-water partition coefficient, radiochemical stability, and cellular uptake. In vivo studies included biodistribution, SPECT/CT imaging, pharmacokinetics, stability and biocompatibility studies were conducted in various mouse models. RESULTS: These six probes exhibited high radiolabeling yields (> 95%) and radiochemical purities (> 95%). In vitro cell uptake and blocking experiments demonstrated their binding capability and specificity for melanin. Among these probes, 99mTc-SMIC-4006 displayed the highest tumor uptake (5.18 ± 1.55%ID/g at 1 h) and significantly higher uptake in B16F10 xenografts compared to non-melanotic A375 xenografts (p < 0.01). The initial tumor-to-blood ratio for 99mTc-SMIC-4006 was 4.30 ± 0.63 at 1 h, increasing to 10.27 ± 5.13 at 6 h. Importantly, SPECT/CT imaging of 99mTc-SMIC-4006 clearly delineated B16F10 tumor regions with high contrast, while A375 xenografts showed minimal uptake. CONCLUSION: 99mTc-SMIC-4006 is a promising SPECT probe for melanoma imaging, offering high tumor specificity, excellent uptake, and ideal tumor-to-background contrast, with strong potential for clinical application.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Tao J, Cao R, Lei Z, et al. Development of 99mTc-labeled melanin-targeted probes for SPECT imaging of melanoma. Eur J Nucl Med Mol Imaging. 2025. PMID: 40257608. doi:10.1007/s00259-025-07268-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。